AIM
ALBO

Advantage Investment Management’s Albireo Pharma Inc ALBO Stock Holding History

Advantage Investment Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-8
Closed – – 1032
2016
Q3 		$0 Hold
8
– – ﹤0.01% 981
2016
Q2 		$0 Hold
8
– – ﹤0.01% 941
2016
Q1 		$0 Hold
8
– – ﹤0.01% 943
2015
Q4 		$0 Hold
8
– – ﹤0.01% 907
2015
Q3 		$0 Hold
8
– – ﹤0.01% 917
2015
Q2 		$0 Hold
8
– – ﹤0.01% 928
2015
Q1 		$0 Hold
8
– – ﹤0.01% 904
2014
Q4 		$0 Buy
+8
New +$351 ﹤0.01% 795

Other funds holding ALBO

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Advantage Investment Management's ALBO Position: Q4 2016 in Review

Advantage Investment Management sold out of Albireo Pharma Inc (ALBO) in Q4 2016, closing a stake of 8 shares.

Advantage Investment Management first reported a position in ALBO in Q4 2014 and held it in 8 quarters. The position peaked at $0 in Q3 2016. 19 funds tracked by Wall St. Rank hold ALBO as of Q4 2016.

  • Advantage Investment Management reported no remaining Albireo Pharma Inc position as of Q4 2016 after selling out during the quarter.
  • Advantage Investment Management sold 8 Albireo Pharma Inc shares in Q4 2016.
  • Advantage Investment Management first reported a position in Albireo Pharma Inc in Q4 2014 and held it in 8 quarters.
  • Advantage Investment Management's Albireo Pharma Inc position peaked at $0 in Q3 2016.
  • 19 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2016.

Based on Advantage Investment Management's 13F filing for Q4 2016, filed 17 Feb 2017.